Related by context. All words. (Click for frequent words.) 83 Orphan Drug designation 80 Orphan Medicinal Product 78 Fast Track Designation 78 orphan medicinal product 78 Orphan Drug Status 77 Orphan Drug designations 77 orphan designation 77 Fast Track Status 76 Orphan Drug Designation 74 Orphan Drug 73 Granted Orphan Drug 73 Orphan designation 73 OMP designation 73 Orphan Designation 73 Orphan Status 73 Fast Track designation 72 orphan drug 72 FDA Orphan Drug 71 granted orphan medicinal 71 Fast Track designations 71 granted orphan 70 Marketing Authorization 70 SNT MC# 70 Application MAA 70 Yondelis ® 70 GTC recombinant form 70 granted Orphan Drug 70 Trobalt 69 Syndrome LEMS 69 Marketing Authorisation 69 Receives Orphan Drug 69 TEMODAL 68 Receives Orphan Drug Designation 68 GTC recombinant human 68 refractory chronic lymphocytic 68 Hexvix ® 68 Lambert Eaton Myasthenic 68 Amrubicin 68 Marketing Authorization Application 68 Marketing Authorisation Application 68 BENLYSTA ® 68 Icatibant 68 histamine dihydrochloride 68 Evoltra ® 68 Cellegesic 68 Mimpara 68 severe gastroparesis 68 Aviptadil 67 OMAPRO ™ 67 FOLOTYN ® 67 Peginterferon alfa 2b 67 Positive Opinion 67 vapreotide acetate 67 sorafenib tablets 67 Civacir 67 YONDELIS 67 Tarceva TM 67 Receives Marketing Authorization 67 Junovan TM 67 TNF Tumor Necrosis Factor 67 Panzem R 67 liver resection surgeries 67 CONBRIZA 67 LymphoStat B belimumab 67 YONDELIS R 67 RELISTOR ® 67 Vandetanib 66 Firazyr 66 Ceflatonin 66 Grants Orphan Drug 66 Medicinal Products EMEA 66 Torisel 66 SYCREST 66 MAGE A3 ASCI 66 novel oral anticoagulant 66 receptor tyrosine kinase inhibitor 66 liposomal formulation 66 Crofelemer budesonide foam 66 PNP inhibitor 66 Vitrasert R 66 Fludara ® 66 Soliris TM eculizumab 66 Febuxostat 66 drug ISA# 66 acetonide FA 66 supplemental Biologics License Application 66 FIRAZYR 66 acyclovir Lauriad R 66 Pafuramidine 66 Receives Fast Track 66 Preotact 66 Serostim ® 66 orally administered inhibitor 66 Receives Positive Opinion 66 Pirfenidone 66 Nexavar tablets 65 Evoltra 65 Raptiva ® 65 Oracea TM 65 Tostrex 65 Teysuno 65 sapropterin dihydrochloride 65 Lenalidomide 65 Loramyc R 65 Pivotal Phase III 65 cutaneous T 65 RoACTEMRA 65 methylnaltrexone bromide 65 pain palliation 65 PGL# 65 Opterone R 65 Silodosin 65 AVASTIN 65 Aplidin 65 MAA submission 65 TORISEL TM 65 Romiplostim 65 novel VDA molecule 65 Priority Review 65 PrevOnco ™ 65 generation purine nucleoside 65 Kit CD# positive 65 Gamunex C 65 Soliris eculizumab 65 Retacrit 65 Zenpep 65 Accelerated Approval 65 PEGylated anti 65 Mutual Recognition Procedure 65 R lenalidomide 65 Meets Primary Endpoint 65 CryoSeal FS System 65 Raptiva R 65 Personalized Immunotherapy 65 ADP receptor antagonist 65 XIAFLEX ™ 64 RANK Ligand inhibitor 64 Bafetinib 64 Voraxaze 64 Firdapse ™ amifampridine phosphate 64 Esbriet pirfenidone 64 ATryn ® 64 Drug Eluting Stent System 64 thalidomide Thalomid 64 LUVENIQ 64 Aurexis 64 Certican 64 Bezielle 64 ixabepilone 64 #D#C# 64 Marketing Authorization Application MAA 64 Alvesco R 64 induced macular edema 64 hypereosinophilic syndrome 64 investigational humanized monoclonal antibody 64 ThermoDox R 64 Cimzia certolizumab pegol 64 human C1 inhibitor 64 Thalidomide Pharmion 64 Firdapse TM amifampridine phosphate 64 oropharyngeal candidiasis OPC 64 Adenuric R 64 Mepact 64 refractory cutaneous T 64 R sorafenib tablets 64 Belimumab 64 FRDA 64 Zorbtive TM 64 Sanvar R 64 myelodysplastic myeloproliferative diseases 64 rilonacept 64 small molecule Hedgehog 64 methylnaltrexone 64 Eribulin 64 ELIQUIS 64 Arzerra ofatumumab 64 Archexin 64 Kuvan R 64 Somatuline Depot 64 Liprotamase 64 neovascular age 64 Cloretazine ® 64 PDE4 inhibitor 64 Nexavar ® 64 Ixempra 64 5 lipoxygenase inhibitor 64 Expanded Indication 64 DORIBAX 64 R Saizen R 64 Nimotuzumab 64 Li Fraumeni Syndrome 64 Preotact R 64 Oracea ® 64 BRILINTA 64 Noxafil 64 Zebinix R 64 Esbriet ® 64 Temsirolimus 64 IgG1 monoclonal antibody 64 targeted radiotherapeutic 64 MabCampath 64 IMA# 64 Marketing Authorization Applications 64 Gleevec imatinib mesylate 64 LHRH antagonist 64 chimeric monoclonal antibody 64 Nexavar sorafenib 64 Pyridorin 63 Entocort 63 HepaGam B 63 IMiDs ® compound 63 UPLYSO 63 Orphan medicinal 63 ATryn ® GTC recombinant 63 Nabi HB Intravenous 63 thetreatment 63 Friedreich Ataxia FRDA 63 Certolizumab pegol 63 Methylnaltrexone 63 Adenuric ® 63 CAMPATH R 63 CYT# potent vascular disrupting 63 FIRMAGON R 63 Gleevec Glivec 63 Xanafide 63 REVLIMID lenalidomide 63 Genasense ® 63 novel emulsion formulation 63 Onconase 63 dasatinib Sprycel ® 63 Campath ® 63 oropharyngeal candidiasis 63 Prodarsan R 63 erlotinib Tarceva ® 63 Hexvix 63 FDA Accepts 63 ATryn R 63 JOULFERON 63 Tibotec Therapeutics division 63 Prestara 63 refractory indolent non 63 Vidaza azacitidine 63 Ciclesonide 63 Onalta 63 refractory acute promyelocytic 63 XIAPEX ® 63 Vimpat ® lacosamide 63 OMNARIS HFA 63 Files IND 63 subsidiaries visit http:/www.apricusbio.com 63 Alitretinoin 63 Evoltra TM 63 rheumatoid arthritis psoriatic arthritis 63 Plicera 63 ZEFTERA TM Zevtera TM 63 ZACTIMA 63 alvimopan 63 Isavuconazole 63 KIACTA ™ 63 Bioral Amphotericin B 63 eprodisate KIACTA TM 63 Vidaza R 63 Clevudine 63 lucinactant 63 Fibrillex TM 63 vemurafenib 63 Market Authorization Application 63 candidates Azedra TM 63 sitaxsentan sodium 63 formerly LymphoStat B 63 Arimoclomol 63 Catena ® 63 Completes Patient Enrollment 63 Ceflatonin R 63 Centralized Procedure 63 IMiDs 63 GW# [003] 63 Investigational Device Exemption 63 Angiox R 63 PrevOnco 63 ONCASPAR 63 PROVENGE ® 63 Bendamustine 63 hyaluronidase enzyme 63 oral prodrug 63 Cx# [002] 63 Tracleer r 63 European Medicines Evaluation 63 IAP inhibitor 63 TAXUS Element Paclitaxel Eluting 63 rasagiline tablets 63 Angiox ® 63 lintuzumab SGN 63 Degarelix 63 Rhucin ® recombinant 63 Actemra tocilizumab 63 pediatric Crohn disease 63 human antithrombin 63 CHMP recommendation 63 Zenvia ™ 63 nasal calcitonin product 63 Amigal TM 63 solifenacin succinate 63 novel synthetic PEGylated 63 Brilique 63 Taxotere docetaxel 63 novel histone deacetylase 63 LUCASSIN 63 docetaxel Taxotere ® 63 Aryplase 63 Ranolazine 63 cinacalcet HCl 63 TYZEKA 63 HuMax TAC 63 Advagraf 63 Movectro 63 sunitinib malate 63 Rhucin R 63 developing Bicifadine serotonin 63 Increlex R 63 Orazol 63 HQK 63 FDA APPROVES 63 R bendamustine hydrochloride 63 tiapamil 63 Intravenous CP 63 mitogen activated ERK kinase 63 miconazole Lauriad R 63 topically applied SEPA 63 Dupuytren Contracture 63 TORISEL 63 PEGylated Fab fragment 63 pralatrexate injection folate analogue 63 REBETOL combination therapy 63 COLAZAL R 62 anticancer compound 62 TO AVOID PREGNANCY WHILE 62 refractory acute myeloid 62 arsenic trioxide injection 62 mTOR inhibitor 62 Tetrabenazine 62 sublingual tablets 62 HepaSphere 62 Basilea Toctino R 62 molecular imaging radiopharmaceutical 62 TRIOLEX HE# APOPTONE HE# 62 CCR5 antagonist 62 proteasome inhibitor 62 Pegloticase 62 Zavesca r 62 Lubiprostone 62 Somatuline R Autogel R 62 Patent Covering 62 Ganite ® 62 highly purified pasteurized 62 Everolimus 62 Onalta ™ 62 investigational pharmacologically unique 62 Telzir 62 Dacogen injection 62 BioNumerik 62 Simulect 62 oxaliplatin Eloxatin 62 Annamycin 62 Cancidas 62 Clolar ® 62 Clofarabine 62 Combination REOLYSIN R 62 Application BLA 62 P#X# antagonist 62 taliglucerase alfa 62 ospemifene 62 Epratuzumab 62 Vicinium TM 62 metaglidasen 62 Pemetrexed 62 Initiates Phase II 62 MYLOTARG 62 MOVIPREP R 62 Genasense R 62 Ambrisentan 62 hoFH 62 Loramyc ™ 62 DC Bead 62 kidney urologic 62 Eprodisate KIACTA TM 62 Tanespimycin 62 phase III isavuconazole 62 opioid induced constipation OIC 62 amrubicin 62 IMiDs ® 62 Uvidem 62 Pathway Inhibitor 62 Initiates Enrollment 62 essential thrombocythemia ET 62 Phase III Clinical Trial 62 oral nucleoside analogue 62 NEBIDO R 62 Safinamide 62 Tasimelteon 62 ATPace TM 62 delivers fluocinolone acetonide FA 62 aerosolized AAT 62 Ceflatonin ® 62 Iluvien ® 62 metastatic castrate resistant 62 Orally administered 62 Initiates Phase III 62 BYETTA ® 62 Entereg R 62 Ceplene ® histamine dihydrochloride 62 Pazopanib 62 FDA Approvable Letter 62 interferon gamma 1b 62 Azedra 62 romidepsin 62 clofarabine 62 ATL# [001] 62 mertansine 62 directed radiotherapeutic antibody 62 LymphoStat B TM 62 Lucanix R 62 OHR/AVR# 62 IMiDs R 62 Gleevec imatinib 62 Angiox 62 INSPIRE Trial Phase III 62 XL# anticancer compounds 62 Troxatyl 62 Intravenous Human 62 Etravirine 62 VISICOL R 62 Saizen ® 62 ALVESCO R 62 SomatoKine 62 Hycamtin 62 Wafer polifeprosan 62 Modrenal R 62 Glybera R 62 Severe VOD 62 Resten NG 62 rALLy clinical trial 62 Patients Treated With 62 Plenaxis R 62 Vascular Wrap TM 62 sorafenib Nexavar 62 BAL# [002] 62 CIMZIA r 62 Submits Response 62 Microplasmin 62 EOquin 62 intranasal formulation 62 arthritis PsA 62 Octreolin 62 granted Orphan Designation 62 DOXIL R 62 mTOR kinase 62 Nivestim 62 depsipeptide 62 Lenocta 62 Cimzia TM 62 Announces Tentative Approval 62 ocular formulation 62 SURFAXIN 62 ankylosing spondylitis psoriatic arthritis 62 lexidronam injection 62 Campath alemtuzumab 62 Jevtana 62 relapsing multiple sclerosis 62 Fingolimod 62 Adjuvant Treatment 62 Bucindolol 62 CIP TRAMADOL ER 62 Prodarsan 62 radiation sensitizer 62 NerPharMa 62 ACOMPLIA R 62 commercialize oritavancin 61 investigational antiplatelet agent 61 Vascugel 61 cell lymphoma CTCL 61 IL# PE#QQR 61 Biologic License Application BLA 61 Dyloject TM 61 ThermoDox ® 61 Advanced Renal Cell 61 Maribavir 61 Aloxi R 61 personalized cellular immunotherapy 61 BLP# Liposome Vaccine 61 efalizumab 61 Albuferon TM 61 Initiate Clinical Trial 61 inhalation powder 61 pediatric exclusivity 61 Irinotecan 61 Removab 61 REVLIMID R 61 AAG geldanamycin analog 61 HepaSphere Microspheres 61 BCG refractory carcinoma 61 SUTENT ® 61 Xyrem ® 61 prokinetic agent 61 systemically administered 61 rufinamide 61 Azacitidine 61 inhaled AAT 61 histone deacetylase HDAC inhibitor 61 mild vasodilator 61 immunotherapeutic vaccine 61 Sapacitabine 61 VIVITROL ® 61 FUSILEV ® 61 Neulasta R 61 modulator SERM 61 targeted antifolate 61 palonosetron 61 oral ridaforolimus 61 eprodisate Fibrillex TM 61 amifampridine phosphate 61 selective estrogen receptor modulator 61 Investigational Compound 61 antibody MT# 61 TRISENOX 61 Fodosine 61 reslizumab 61 known teratogen substance 61 SPL# Gel vaginal microbicide 61 BrachySil TM 61 forodesine 61 tamibarotene 61 Vascular Disrupting Agent 61 treat chronic sinusitis 61 dirucotide MBP# 61 markets HP Acthar 61 Hsp# Inhibitor 61 Ganciclovir 61 Phase 2b Clinical Trial 61 Edurant 61 registrational 61 Complicated Skin 61 vinorelbine emulsion 61 Torisel temsirolimus 61 Prestara TM 61 Multiferon 61 GVAX cancer 61 terlipressin 61 Diamyd ® 61 NeuroSTAT ® 61 oral dual endothelin 61 ® lenalidomide 61 CEQ# 61 vitreoretinal disorders 61 histone deacetylase inhibitor 61 Pralatrexate 61 Recombinant Human 61 Luveniq 61 Hodgkin lymphoma HL 61 endothelin antagonist 61 Bazedoxifene 61 Sevelamer 61 SEBIVO 61 silodosin 61 Cimzia ® certolizumab pegol 61 radiotherapeutic 61 Campto 61 PKC# 61 Soft Tissue Sarcoma 61 vascular disrupting agent 61 Glatiramer Acetate 61 Rapinyl 61 RhuDex R 61 Expedited Review 61 Behcet uveitis 61 selective A2A adenosine receptor 61 Arranon 61 Vorinostat 61 temsirolimus 61 pregabalin Lyrica 61 MERREM 61 Rhucin ® 61 Topotecan 61 RhuDex ® 61 Supplemental Biologics License Application 61 markets Gelclair R 61 PHASE III 61 Japanese Encephalitis Vaccine 61 Receives Approvable Letter 61 mocetinostat MGCD# 61 Arzerra TM 61 AA amyloidosis 61 CCR9 antagonist 61 mTOR mammalian target 61 antibody MAb 61 Glufosfamide 61 ALN TTR 61 Combidex 61 relapsing remitting MS RRMS 61 Pivotal Trial 61 Bosutinib 61 virus HCV protease inhibitor 61 octreotide implant 61 TheraCIM 61 ELND# 61 Junovan 61 multiple myeloma MM 61 ZOLINZA 61 EOquin TM 61 Kepivance 61 Trovax 61 Abstral ® 61 sunitinib Sutent 61 Sutent sunitinib 61 Neupro R 61 Afatinib 61 Bayer Nexavar 61 icatibant 61 Loramyc 61 thymalfasin 61 granted Ortec 61 zolpidem tartrate sublingual tablet 61 MGd 61 Orathecin 61 synthetic peptide containing 61 ketolide antibiotic 61 ONGLYZA ™ 61 registrational trial 61 PD LID 61 successfully commercialize Iluvien 61 miconazole Lauriad ® 61 HuMax 61 Loramyc ® 61 Herceptin trastuzumab 61 ELACYT 61 granted Fast Track 61 sNDAs 61 idursulfase 61 treat opioid induced 61 Taliglucerase alfa 61 Argatroban 61 Rituxan rituximab 61 valtorcitabine 61 photoprotective drug 61 Cladribine Tablets 61 oncology indications 61 severe hypercholesterolemia 61 alfa 2a 61 mesylate tablets approved 61 Severe Sepsis 61 BLA filing 61 dihydrochloride 61 Avastin bevacizumab 61 Panzem R NCD 61 PI3K/Akt pathway inhibitor 61 unique alkylating agent 61 volociximab 61 advanced carcinoid 61 oral beclomethasone dipropionate 61 exocrine pancreatic insufficiency EPI 61 ISTODAX 61 Impax ANDA 61 registrational studies 61 Toctino R 61 DNA demethylating agent 61 metastatic malignant 61 topical gel formulation 61 tramiprosate 60 lymphoid malignancies 60 Besivance 60 CRMD# 60 Granulocyte Colony Stimulating Factor 60 ARIKACE ™ 60 SPRYCEL ® 60 beta 1a 60 Traficet EN 60 MTP inhibitor 60 catheter occlusion 60 ZEVALIN ® 60 GATTEX TM 60 incyclinide 60 TRANSDUR ® 60 NAVISTAR R 60 Fortical R 60 OvaRex ® MAb 60 Satraplatin 60 etanercept Enbrel 60 BCR ABL inhibitor 60 AZILECT R 60 gemcitabine Gemzar ® 60 chronic eosinophilic leukemia 60 Squalamine 60 Enzyme Replacement Therapy 60 Tengion Neo Bladder Augment 60 Budesonide foam crofelemer 60 Apaziquone 60 CLIA waiver 60 Troxatyl TM 60 Initiates Clinical Trial 60 Mycophenolate Mofetil 60 apricitabine 60 Navelbine ® 60 rotigotine transdermal patch 60 Zarnestra 60 Reports Preclinical Data 60 Cutaneous T 60 Phase #b/#a clinical 60 Aflibercept 60 Pixantrone 60 Allovectin 7 60 Metformin HCl 60 Increlex ® 60 inhibit oxidative stress 60 docetaxel Taxotere R 60 Telatinib 60 pseudobulbar affect PBA 60 fosbretabulin 60 Manja Bouman CEO 60 synthetic lipoglycopeptide antibiotic 60 Rilonacept 60 CTAP# Capsules 60 Tyrima 60 Scientific Advice 60 tocilizumab 60 HuMax EGFr 60 Onalta TM 60 vinca alkaloid 60 bevacizumab Avastin ® 60 herpetic keratitis 60 HuMax CD4 60 Immune Globulin Human 60 PROCHYMAL 60 QuadraSphere 60 small molecule thrombopoietin 60 Glybera 60 SinuNase TM 60 Preclinical studies suggest 60 VivaGel ™ 60 JAK2 Inhibitor 60 Abiraterone acetate 60 omacetaxine mepesuccinate 60 pan histone deacetylase 60 tramiprosate ALZHEMED TM 60 ADVEXIN 60 QUADRAMET R 60 prasterone 60 ZADAXIN ® 60 Dabigatran etexilate 60 Urocidin 60 Inhaled AAT 60 intravesical infusion therapy 60 afamelanotide 60 Ophena TM 60 PROMACTA 60 diarrhea predominant irritable 60 Darunavir 60 systemic immunosuppressive drugs 60 corticosteroid dexamethasone 60 Tigecycline 60 fostamatinib 60 Revlimid lenalidomide 60 CHMP opinion 60 Alvesco ® 60 VitiGam TM 60 Achieves Primary Endpoint 60 Efficacy Results 60 Prolongs Survival 60 thrombolytic agent 60 Virulizin ® 60 Zebinix 60 acadesine 60 ARCOXIA 60 gastrointestinal stromal tumors 60 TM pralatrexate injection 60 Biological License Application 60 k Premarket Notification 60 peripherally acting 60 Actimmune ® 60 Proquin XR 60 metastatic hormone refractory 60 Albugon 60 MORAb 60 chronic idiopathic thrombocytopenic purpura 60 Marqibo TM 60 ADVEXIN p# therapy 60 pancreatic enzyme replacement 60 hormone LHRH antagonist 60 orally inhaled 60 Vidofludimus 60 IRESSA 60 CINTREDEKIN BESUDOTOX 60 Temodar ® 60 Investigational Treatment 60 Serdolect ® 60 Cinacalcet HCl 60 tramiprosate Alzhemed TM 60 Daclizumab 60 Vasovist 60 HIV protease inhibitor 60 BEXXAR 60 demonstrated antitumor activity 60 Pruvel 60 Alfa Wassermann 60 HDAC Inhibitor 60 bortezomib Velcade 60 Drug Candidate 60 Prosaptide 60 Tolvaptan 60 pediatric acute lymphoblastic 60 Etanercept 60 Dapagliflozin 60 Carfilzomib 60 seliciclib CYC# 60 nucleoside analog 60 RoActemra 60 MuGard TM 60 Initiate Phase 60 Cloretazine 60 drug GAP #B# 60 Alair System 60 Cerepro ® 60 acute HAE attacks 60 dihydrochloride Tablets 60 Increlex TM 60 BioSTAR R 60 5 HT3 antagonist 60 Onco TCS 60 Biologics License Application 60 highly selective inhibitor 60 CINQUIL 60 targeting CD# 60 Somatuline Autogel 60 trade name Normix 60 aripiprazole Abilify 60 Genasense ® oblimersen 60 relapsed leukemia 60 pioglitazone HCl 60 selective modulator 60 XIAFLEX ® 60 Doripenem 60 Swissmedic 60 Rebif ® 60 treat lupus renal 60 phase IIb clinical 60 BiovaxID TM 60 ZALBIN 60 clobazam 60 trabectedin 60 Zirgan 60 huN# DM1 60 XIAPEX 60 investigational atypical antipsychotic 60 Fresenius Biotech 60 cysteamine bitartrate 60 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 60 oral anti arrhythmic 60 Inhalation Aerosol 60 Files Investigational 60 psoriasis rheumatoid arthritis 60 BLA submission 60 Serostim R 60 TRISENOX ® 60 TKB# 60 PROGENSA R 60 IV acetaminophen 60 Retisert ® 60 huC# DM4 60 AEG# 60 ASP# 60 include Alferon N 60 infusional 5-FU/LV 60 ELAPRASE 60 Insegia 60 V Everolimus Eluting Coronary 60 adenosine injection 60 MKC# MKC# PP 60 VALSTAR 60 Initiates Clinical 60 inhaled liposomal ciprofloxacin 60 CE Marked 60 investigational oral inhibitor 60 LEUKINE 60 NEUMUNE 60 SYN# 60 Tezampanel 60 Phase IIb Trial 60 mGluR2 positive 60 Tesamorelin 60 imatinib Gleevec ® 60 HGS# 60 prucalopride 60 rxRNA 60 OMAPRO 60 Sodium oxybate 60 RNAi therapeutic targeting 60 Emezine 60 orBec 60 Abstral 60 Saxagliptin 60 Loramyc TM 60 Alferon LDO 60 ATG Fresenius S 60 Tamibarotene 60 Pharmacokinetics PK 60 GAMMAGARD 60 Ruconest 60 CytoFab 60 HP Acthar Gel repository 60 Arikace 60 Keppra ® levetiracetam 60 European Marketing Authorizations 60 gastrointestinal disorders characterized 60 NUEDEXTA ™ 60 Proxinium TM 60 Benlysta belimumab 60 ciprofloxacin hydrochloride 60 TroVax ® 60 hyperphenylalaninemia HPA due 60 agalsidase alfa 60 p# MAP kinase inhibitor 60 CellCept mycophenolate mofetil 60 Mitoxantrone 60 product platforms AZX# 60 SUPPRELIN R LA 60 Perifosine 60 Virulizin R 60 Darinaparsin 60 atacicept 60 Velaglucerase Alfa 60 TRIST study 60 mesylate 60 Linjeta TM 60 DIFICID ™ 60 Eloxatin ® 59 severe oral mucositis 59 Iluvien TM 59 PROMACTA ® 59 lorvotuzumab mertansine 59 Mylan Receives Approval 59 Omapro 59 Presents Preclinical Data 59 R adalimumab 59 Camptosar ® 59 Onrigin 59 IONSYS TM 59 humanized monoclonal antibody 59 DepoDur 59 Cinryze ™ 59 initiated Phase Ib 59 miconazole MBT 59 palifermin 59 pancreatic insufficiency 59 fluoropyrimidine 59 Telavancin 59 Submits NDA 59 REBETOL combination 59 Zidovudine Tablets 59 oral dihydropyrimidine dehydrogenase DPD 59 USFDA approval 59 Gemzar ® 59 investigational pan BCR 59 dextromethorphan quinidine 59 Exelixis XL# 59 Prospective Randomized 59 Fludarabine 59 RESOLOR 59 Targretin capsules 59 Humira adalimumab 59 HeartWare System 59 adult chronic ITP 59 everolimus tablets 59 SJIA 59 Entereg TM 59 treat male hypogonadism 59 Gel repository corticotropin injection 59 dual endothelin receptor antagonist 59 diagnostic molecular imaging 59 Plasmin 59 IMPDH inhibitor 59 Familial Adenomatous Polyposis FAP 59 CE IVD 59 Phase 1b clinical trials 59 Development OOPD 59 polymerase inhibitor 59 Evoltra R 59 Biopartners 59 Eraxis 59 multicenter Phase III 59 oral ghrelin agonist 59 Velcade bortezomib 59 immunotherapeutic agent 59 Cardium Therapeutics TM 59 Subpart E 59 STEDESA 59 XYOTAX TM 59 Toctino ® 59 Fx #A 59 Bayer Onyx 59 vaccines oncolytic virus